2-130342125-T-A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2

The NM_032357.4(VMA22):​c.1A>T​(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 31)

Consequence

VMA22
NM_032357.4 initiator_codon

Scores

6
1
9

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.927

Publications

0 publications found
Variant links:
Genes affected
VMA22 (HGNC:28178): (coiled-coil domain containing 115) The protein encoded by this gene has been observed to localize to the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) and coat protein complex I (COPI) vesicles in some human cells. The encoded protein shares some homology with the yeast V-ATPase assembly factor Vma22p, and the orthologous protein in mouse promotes cell proliferation and suppresses cell death. Defects in this gene are a cause of congenital disorder of glycosylation, type IIo in humans. [provided by RefSeq, Mar 2016]
VMA22 Gene-Disease associations (from GenCC):
  • CCDC115-CDG
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032357.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 4 pathogenic variants. Next in-frame start position is after 49 codons. Genomic position: 130341911. Lost 0.267 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032357.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VMA22
NM_032357.4
MANE Select
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 5NP_115733.2
VMA22
NM_001321119.2
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 5NP_001308048.2
VMA22
NM_001321118.1
c.96+9A>T
intron
N/ANP_001308047.1B8ZZ99

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VMA22
ENST00000259229.7
TSL:1 MANE Select
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 5ENSP00000259229.2Q96NT0-1
VMA22
ENST00000902736.1
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 6ENSP00000572795.1
VMA22
ENST00000902734.1
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 5ENSP00000572793.1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.36
CADD
Benign
20
DANN
Benign
0.87
DEOGEN2
Benign
0.032
T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.15
N
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.041
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Benign
-1.1
T
PhyloP100
0.93
PROVEAN
Benign
-0.72
N
REVEL
Benign
0.24
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
PromoterAI
-0.34
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.96
gMVP
0.41
Mutation Taster
=74/126
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs752919660;
hg19: chr2-131099698;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.